Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leiomyoma 8Myofibroma 1Fibroma 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Tamoxifen 12Chemotherapy, Adjuvant 9Radiotherapy 7Anastrozole 6Neoadjuvant Therapy 5Magnetic Resonance Spectroscopy 5Letrozole 5Gene Expression Profiling 5Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Early Intervention, Educational 4Counseling 4Sentinel Lymph Node Biopsy 3Reverse Transcriptase Polymerase Chain Reaction 3High-Energy Shock Waves 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3Biopsy 3afimoxifene 2Trastuzumab 2Surgical Procedures, Operative 2Soybean Proteins 2Simvastatin 2Radiotherapy, Conformal 2Radiation 2Methods 2Mastectomy 2Fish Oils 2Caregivers 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Intraductal, Noninfiltrating × telapristone acetate × Clear all
NCT02314156 2023-02-22

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Northwestern University

Phase 2 Completed
67 enrolled 14 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡